Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Alvaro Moreno

Showing results (111-120 of 129) with videos related to

Pageof 13
Sort By:
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|April 5, 2017
Impact of Diabetes, Insulin, and Metformin Use on the Outcome of Patients With Human Epidermal Growth Factor Receptor 2-Positive Primary Breast Cancer: Analysis From the ALTTO Phase III Randomized TrialAmir Sonnenblick, Dominique Agbor-Tarh, Ian Bradbury, et al.
Breast Cancer Research and Treatment|June 15, 2017
Prolonged survival in patients with breast cancer and a history of brain metastases: results of a preplanned subgroup analysis from the randomized phase III BEACON trialJavier Cortés, Hope S Rugo, Ahmad Awada, et al.
Mayo Clinic Proceedings. Innovations, Quality & Outcomes|December 20, 2021
Humoral Responses After SARS-CoV-2 mRNA Vaccination and Breakthrough Infection in Cancer PatientsSaranya Chumsri, Pooja P Advani, Tanmayi S Pai, et al.
Journal of the National Cancer Institute|June 8, 2018
Adjuvant Anti-HER2 Therapy, Treatment-Related Amenorrhea, and Survival in Premenopausal HER2-Positive Early Breast Cancer PatientsMatteo Lambertini, Christine Campbell, José Bines, et al.
Breast Cancer Research and Treatment|April 22, 2017
SLCO1B1 polymorphisms and plasma estrone conjugates in postmenopausal women with ER+ breast cancer: genome-wide association studies of the estrone pathwayTanda M Dudenkov, James N Ingle, Aman U Buzdar, et al.
JCO Clinical Cancer Informatics|June 23, 2023
Operational Metrics for the ELAINE 2 Study Combining a Traditional Approach With a Just-in-TIME ModelSibel Blau, Julio Antonio Peguero, Halle C F Moore, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|June 3, 2021
Patient-Derived Xenograft Engraftment and Breast Cancer Outcomes in a Prospective Neoadjuvant Study (BEAUTY)Judy C Boughey, Vera J Suman, Jia Yu, et al.
Clinical Pharmacology and Therapeutics|January 17, 2019
Anastrozole Aromatase Inhibitor Plasma Drug Concentration Genome-Wide Association Study: Functional Epistatic Interaction Between SLC38A7 and ALPPL2Tanda M Dudenkov, Duan Liu, Junmei Cairns, et al.
The Journal of Clinical Investigation|May 1, 2018
DNA methyltransferase expression in triple-negative breast cancer predicts sensitivity to decitabineJia Yu, Bo Qin, Ann M Moyer, et al.
Origins of Life and Evolution of the Biosphere : the Journal of the International Society for the Study of the Origin of Life|August 11, 2019
Hidden Concepts in the History and Philosophy of Origins-of-Life Studies: a Workshop ReportCarlos Mariscal, Ana Barahona, Nathanael Aubert-Kato, et al.
Pageof 13

Showing results (111-120 of 129) with videos related to

Sort By:
Pageof 13
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|April 5, 2017
Impact of Diabetes, Insulin, and Metformin Use on the Outcome of Patients With Human Epidermal Growth Factor Receptor 2-Positive Primary Breast Cancer: Analysis From the ALTTO Phase III Randomized TrialAmir Sonnenblick, Dominique Agbor-Tarh, Ian Bradbury, et al.
Breast Cancer Research and Treatment|June 15, 2017
Prolonged survival in patients with breast cancer and a history of brain metastases: results of a preplanned subgroup analysis from the randomized phase III BEACON trialJavier Cortés, Hope S Rugo, Ahmad Awada, et al.
Mayo Clinic Proceedings. Innovations, Quality & Outcomes|December 20, 2021
Humoral Responses After SARS-CoV-2 mRNA Vaccination and Breakthrough Infection in Cancer PatientsSaranya Chumsri, Pooja P Advani, Tanmayi S Pai, et al.
Journal of the National Cancer Institute|June 8, 2018
Adjuvant Anti-HER2 Therapy, Treatment-Related Amenorrhea, and Survival in Premenopausal HER2-Positive Early Breast Cancer PatientsMatteo Lambertini, Christine Campbell, José Bines, et al.
Breast Cancer Research and Treatment|April 22, 2017
SLCO1B1 polymorphisms and plasma estrone conjugates in postmenopausal women with ER+ breast cancer: genome-wide association studies of the estrone pathwayTanda M Dudenkov, James N Ingle, Aman U Buzdar, et al.
JCO Clinical Cancer Informatics|June 23, 2023
Operational Metrics for the ELAINE 2 Study Combining a Traditional Approach With a Just-in-TIME ModelSibel Blau, Julio Antonio Peguero, Halle C F Moore, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|June 3, 2021
Patient-Derived Xenograft Engraftment and Breast Cancer Outcomes in a Prospective Neoadjuvant Study (BEAUTY)Judy C Boughey, Vera J Suman, Jia Yu, et al.
Clinical Pharmacology and Therapeutics|January 17, 2019
Anastrozole Aromatase Inhibitor Plasma Drug Concentration Genome-Wide Association Study: Functional Epistatic Interaction Between SLC38A7 and ALPPL2Tanda M Dudenkov, Duan Liu, Junmei Cairns, et al.
The Journal of Clinical Investigation|May 1, 2018
DNA methyltransferase expression in triple-negative breast cancer predicts sensitivity to decitabineJia Yu, Bo Qin, Ann M Moyer, et al.
Origins of Life and Evolution of the Biosphere : the Journal of the International Society for the Study of the Origin of Life|August 11, 2019
Hidden Concepts in the History and Philosophy of Origins-of-Life Studies: a Workshop ReportCarlos Mariscal, Ana Barahona, Nathanael Aubert-Kato, et al.
Pageof 13